ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00363714
Recruitment Status : Completed
First Posted : August 15, 2006
Last Update Posted : August 18, 2008
Sponsor:
Collaborator:
Sirna Therapeutics Inc.
Information provided by:
Allergan

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2007
  Actual Study Completion Date : April 2007